CA2974066C — Method for modifying t cell population
Assigned to International Institute of Cancer Immunology Inc · Expires 2025-05-06 · 1y expired
What this patent protects
The invention relates to a method for increasing the proportion of memory T lymphocytes in a population of T lymphocytes, said method comprising a step of adding a modulator of the retinoid metabolic pathway and/or a modulator of the retinoic acid signaling system to the populati…
USPTO Abstract
The invention relates to a method for increasing the proportion of memory T lymphocytes in a population of T lymphocytes, said method comprising a step of adding a modulator of the retinoid metabolic pathway and/or a modulator of the retinoic acid signaling system to the population of T lymphocytes.
Drugs covered by this patent
- Invokana (CANAGLIFLOZIN) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.